FDA Inspection
Baxter Healthcare CorporationBaxter Healthcare Corporation – FDA Inspection, Sep 28, 2016
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on September 28, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 28, 2016
- Product Type
- Drugs
View Company Profile
ID · 17184122-ebcd-46e0-9281-1d503145b42f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 988263
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 314.80(b)Failure to review ADE information
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxter Healthcare Corporation
10| Date | Classification | Office | Project area |
|---|---|---|---|
| February 6, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 9, 2022 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| August 8, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 10, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 5, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1230610 - 2024-02-06
- FDA Inspection 1171501 - 2022-06-09
- FDA Inspection 1067768 - 2018-08-08
- FDA Inspection 921291 - 2015-04-10
- FDA Inspection 827281 - 2013-04-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.